Rhythm Pharmaceuticals
Markets IMCIVREE and develops MC4R agonists for rare neuroendocrine obesity disorders.
$107.17
After-hours close−0.10 (−0.09%)
At close$107.27(−4.67%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.73 | — | — |
| Aug 2026 | −$0.81 | −$0.73 | +9.6% |
| May 2026 | −$0.86 | −$0.83 | +3.5% |
| Feb 2026 | −$0.79 | −$0.73 | +7.6% |
| Nov 2025 | −$0.72 | −$0.82 | −13.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Oct 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.73 | — | — | $83.9M | — | — |
| Aug 4, 2026 | −$0.81 | −$0.73 | +9.6% | $67.7M | $71.3M | +5.3% |
| May 5, 2026 | −$0.86 | −$0.83 | +3.5% | $55.8M | $60.1M | +7.8% |
| Feb 26, 2026 | −$0.79 | −$0.73 | +7.6% | $56.2M | $57.3M | +1.9% |
| Nov 4, 2025 | −$0.72 | −$0.82 | −13.9% | $56.0M | $51.3M | −8.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 1, 2023 | ||||||
| May 2, 2023 | ||||||
| Mar 1, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 2, 2022 | ||||||
| May 3, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 2, 2021 | ||||||
| Aug 3, 2021 | ||||||
| May 3, 2021 | ||||||
| Mar 1, 2021 | ||||||
| Nov 2, 2020 | ||||||
| Aug 3, 2020 | ||||||
| May 4, 2020 | ||||||
| Mar 2, 2020 | ||||||
| Nov 1, 2019 | ||||||
| Jul 29, 2019 | ||||||
| May 3, 2019 | ||||||
| Mar 8, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 14, 2018 | ||||||
| Mar 12, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Oct 5, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||